COO vs RIGL · P/E 36, rev $4.09B vs P/E 9.1, rev $137.5M
The Cooper Companies, Inc (COO) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported RIGL revenue for 2026-06-30 was $137.5M. Net income was $25.9M. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
COO currently screens at market cap $14.92B and trailing P/E 36.1. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the COO and RIGL stock pages for the full models.
Not investment advice.